SF Healthcare Week: Beam's CEO John Evans shares an update on based editing for alpha-1 antitrypsin deficiency, sickle cell disease, and more
BiotechTV - News
00:00
Why base editing fits alpha-1
John contrasts RNA and other approaches and argues base editing directly corrects the DNA root cause for alpha-1.
Play episode from 03:41
Transcript
